TP53 and osteosarcoma: More recently, we described that in wild-type p53-containing osteosarcoma U2OS cells, and not in p53-null Saos and p53-mutant MG63 osteosarcoma cells, Pi is capable of inducing sensitization to doxorubicin in a p53-dependent manner (18).